Publicação:
Elevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsia

dc.contributor.authorRomão, Mariana [UNESP]
dc.contributor.authorWeel, Ingrid Cristina [UNESP]
dc.contributor.authorLifshitz, Shirlee Jaffe
dc.contributor.authorPeraçoli, Maria Terezinha Serrão [UNESP]
dc.contributor.authorWitkin, Steven Sol [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionWeill Cornell Medical College
dc.date.accessioned2014-05-27T11:30:41Z
dc.date.available2014-05-27T11:30:41Z
dc.date.issued2013-09-11
dc.description.abstractPurpose: Preeclampsia (PE) is a specific syndrome of pregnancy clinically identified by hypertension and proteinuria from the 20th week of gestation associated with a systemic inflammatory response and oxidative stress. While pro-inflammatory cytokines have been extensively studied in PE, other factors in the circulation that also influence the magnitude of inflammation have received much less attention. The present study compared serum concentrations of five immune-regulatory compounds in normotensive pregnant women and in women with gestational hypertension (GH) or PE. Methods: Sixty women with PE, 53 with GH and 40 normotensive women paired by gestational age were evaluated. Sera were evaluated for concentrations of extracellular matrix metalloproteinase inducer (EMMPRIN), hyaluronan, gelsolin, visfatin and histone 2B by ELISA. Differences between groups were analyzed by nonparametric tests, with a significance level of 5 %. Results: Increased levels of EMMPRIN and hyaluronan were present in preeclamptic women as compared to the GH and normotensive groups. There was no difference between groups in gelsolin, visfatin or histone 2B. Conclusion: Increased release of EMMPRIN and hyaluronan may contribute to an elevated pro-inflammatory response and tissue damage in women with PE. © 2013 Springer-Verlag Berlin Heidelberg.en
dc.description.affiliationDepartment of Gynecology and Obstetrics, Botucatu Medical School São Paulo State University, Botucatu, São Paulo
dc.description.affiliationDivision of Immunology and Infectious Diseases, Department of Obstetrics and Gynecology Weill Cornell Medical College, 525 East 68th Street, New York, 10065
dc.description.affiliationDepartment of Microbiology and Immunology Institute of Biosciences, São Paulo State University, Botucatu
dc.description.affiliationUnespDepartment of Gynecology and Obstetrics, Botucatu Medical School São Paulo State University, Botucatu, São Paulo
dc.description.affiliationUnespDepartment of Microbiology and Immunology Institute of Biosciences, São Paulo State University, Botucatu
dc.format.extent1-5
dc.identifierhttp://dx.doi.org/10.1007/s00404-013-3021-7
dc.identifier.citationArchives of Gynecology and Obstetrics, p. 1-5.
dc.identifier.doi10.1007/s00404-013-3021-7
dc.identifier.issn0932-0067
dc.identifier.issn1432-0711
dc.identifier.lattes6486557387397806
dc.identifier.scopus2-s2.0-84883510264
dc.identifier.urihttp://hdl.handle.net/11449/76544
dc.identifier.wosWOS:000331637100018
dc.language.isoeng
dc.relation.ispartofArchives of Gynecology and Obstetrics
dc.relation.ispartofjcr2.236
dc.relation.ispartofsjr0,956
dc.relation.ispartofsjr0,956
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectEMMPRIN
dc.subjectGestational hypertension
dc.subjectHyaluronan
dc.subjectInflammation
dc.subjectPreeclampsia
dc.titleElevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsiaen
dc.typeArtigo
dcterms.licensehttp://www.springer.com/open+access/authors+rights
dspace.entity.typePublication
unesp.advisor.lattes6486557387397806
unesp.author.orcid0000-0002-8990-0237[1]
unesp.author.orcid0000-0002-0936-9512[4]
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências, Botucatupt
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentGinecologia e Obstetrícia - FMBpt
unesp.departmentMicrobiologia e Imunologia - IBBpt

Arquivos